Jose Garrido5,Eduard Masvidal-Codina1,Nicola Ria1,Fikret Duvan1,Bruno Rodríguez-Meana2,Xavi Illa3,Kostas Kostarelos1,4,Xavier Navarro2,Anton Guimerà-Brunet3
Catalan Institute of Nanoscience and Nanotechnology (ICN2)1,Institute of Neurosciences, Physiology and Immunology, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Universitat Autònoma de Barcelona2,Instituto de Microelectrónica de Barcelona IMB-CNM (CSIC), Esfera UAB3,Nanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine & Health4,ICREA5
Jose Garrido5,Eduard Masvidal-Codina1,Nicola Ria1,Fikret Duvan1,Bruno Rodríguez-Meana2,Xavi Illa3,Kostas Kostarelos1,4,Xavier Navarro2,Anton Guimerà-Brunet3
Catalan Institute of Nanoscience and Nanotechnology (ICN2)1,Institute of Neurosciences, Physiology and Immunology, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Universitat Autònoma de Barcelona2,Instituto de Microelectrónica de Barcelona IMB-CNM (CSIC), Esfera UAB3,Nanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine & Health4,ICREA5
Establishing a reliable bidirectional communication interface between the nervous system and electronic devices is crucial for exploiting the full potential of neurotechnology. Despite recent advancements, current technologies evidence important shortcomings, e.g. lack of focal stimulation, low signal-to-noise ratio, etc. Thus, efforts to explore novel materials are essential for the development of next-generation neural interfaces. Graphene and graphene-based materials possess a very attractive set of physicochemical properties holding great potential for biomedical applications, in particular for implantable neural interfaces. This presentation provides an overview on fundamentals and applications of several graphene-based technologies and devices aiming at developing an efficient bidirectional communication with the nervous system. The main goal of this talk is to discuss opportunities of graphene-based neurotechnologies in neuroscience and implantable medical applications, and at the same time to identify the main challenges ahead.<br/><br/>This work has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement N. 881603 (GrapheneCore3); from the European Union’s Horizon Europe research and innovation programme under grant agreement N. 101070865 (MINIGRAPH), that is supported by the Swiss State Secretariat for Education, Research and Innovation (SERI) under contract number 22.00163); and from the Proyecto PCI2021-122095-2A financiado por MCIN/AEI /10.13039/501100011033 y por la Unión Europea NextGenerationEU/PRTR.